nodes	percent_of_prediction	percent_of_DWPC	metapath
SIMEPREVIR—P-Glycoprotein Inhibitors—Everolimus—kidney cancer	0.227	0.352	CiPCiCtD
SIMEPREVIR—Cytochrome P450 3A4 Inhibitors—Pazopanib—kidney cancer	0.209	0.324	CiPCiCtD
SIMEPREVIR—Cytochrome P450 3A4 Inhibitors—Everolimus—kidney cancer	0.209	0.324	CiPCiCtD
SIMEPREVIR—ABCB1—kidney cancer	0.0901	1	CbGaD
SIMEPREVIR—SLCO1B1—Pazopanib—kidney cancer	0.0323	0.161	CbGbCtD
SIMEPREVIR—ABCB1—Temsirolimus—kidney cancer	0.0176	0.0878	CbGbCtD
SIMEPREVIR—CYP3A4—Everolimus—kidney cancer	0.0156	0.0778	CbGbCtD
SIMEPREVIR—ALB—Erlotinib—kidney cancer	0.0126	0.0629	CbGbCtD
SIMEPREVIR—CYP1A2—Pazopanib—kidney cancer	0.0106	0.0527	CbGbCtD
SIMEPREVIR—CYP3A4—Temsirolimus—kidney cancer	0.0106	0.0526	CbGbCtD
SIMEPREVIR—ABCB1—Pazopanib—kidney cancer	0.00926	0.0461	CbGbCtD
SIMEPREVIR—ABCB1—Dactinomycin—kidney cancer	0.00847	0.0422	CbGbCtD
SIMEPREVIR—CYP1A2—Erlotinib—kidney cancer	0.00756	0.0376	CbGbCtD
SIMEPREVIR—ABCB1—Gemcitabine—kidney cancer	0.0067	0.0333	CbGbCtD
SIMEPREVIR—ABCB1—Erlotinib—kidney cancer	0.00661	0.0329	CbGbCtD
SIMEPREVIR—CYP1A2—Sorafenib—kidney cancer	0.00614	0.0306	CbGbCtD
SIMEPREVIR—ABCB1—Paclitaxel—kidney cancer	0.00605	0.0301	CbGbCtD
SIMEPREVIR—CYP3A4—Pazopanib—kidney cancer	0.00555	0.0276	CbGbCtD
SIMEPREVIR—ABCB1—Sorafenib—kidney cancer	0.00537	0.0267	CbGbCtD
SIMEPREVIR—ABCB1—Vinblastine—kidney cancer	0.00531	0.0264	CbGbCtD
SIMEPREVIR—ABCB1—Vincristine—kidney cancer	0.00522	0.026	CbGbCtD
SIMEPREVIR—ABCB1—Sunitinib—kidney cancer	0.00435	0.0217	CbGbCtD
SIMEPREVIR—CYP3A4—Erlotinib—kidney cancer	0.00396	0.0197	CbGbCtD
SIMEPREVIR—CYP3A4—Paclitaxel—kidney cancer	0.00362	0.018	CbGbCtD
SIMEPREVIR—ABCB1—Doxorubicin—kidney cancer	0.00326	0.0162	CbGbCtD
SIMEPREVIR—CYP3A4—Sorafenib—kidney cancer	0.00322	0.016	CbGbCtD
SIMEPREVIR—CYP3A4—Vinblastine—kidney cancer	0.00318	0.0158	CbGbCtD
SIMEPREVIR—CYP3A4—Vincristine—kidney cancer	0.00313	0.0156	CbGbCtD
SIMEPREVIR—CYP3A4—Sunitinib—kidney cancer	0.00261	0.013	CbGbCtD
SIMEPREVIR—CYP3A4—Doxorubicin—kidney cancer	0.00195	0.00972	CbGbCtD
SIMEPREVIR—Blood bilirubin increased—Temsirolimus—kidney cancer	0.00085	0.0206	CcSEcCtD
SIMEPREVIR—Hyperbilirubinaemia—Pazopanib—kidney cancer	0.000833	0.0202	CcSEcCtD
SIMEPREVIR—Blood bilirubin increased—Pazopanib—kidney cancer	0.000801	0.0194	CcSEcCtD
SIMEPREVIR—CYP1A2—urine—kidney cancer	0.000746	0.153	CbGeAlD
SIMEPREVIR—Blood bilirubin increased—Everolimus—kidney cancer	0.000632	0.0153	CcSEcCtD
SIMEPREVIR—Blood bilirubin increased—Sorafenib—kidney cancer	0.000549	0.0133	CcSEcCtD
SIMEPREVIR—CYP3A4—urine—kidney cancer	0.00054	0.111	CbGeAlD
SIMEPREVIR—CTSS—renal system—kidney cancer	0.00053	0.109	CbGeAlD
SIMEPREVIR—Blood bilirubin increased—Sunitinib—kidney cancer	0.000528	0.0128	CcSEcCtD
SIMEPREVIR—CTSS—kidney—kidney cancer	0.000512	0.105	CbGeAlD
SIMEPREVIR—CTSS—cortex of kidney—kidney cancer	0.000499	0.102	CbGeAlD
SIMEPREVIR—CTSS—gonad—kidney cancer	0.000475	0.0975	CbGeAlD
SIMEPREVIR—Hyperbilirubinaemia—Gemcitabine—kidney cancer	0.000441	0.0107	CcSEcCtD
SIMEPREVIR—Photosensitivity reaction—Pazopanib—kidney cancer	0.000434	0.0105	CcSEcCtD
SIMEPREVIR—Blood bilirubin increased—Gemcitabine—kidney cancer	0.000424	0.0103	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Pazopanib—kidney cancer	0.000401	0.00972	CcSEcCtD
SIMEPREVIR—Hyperbilirubinaemia—Paclitaxel—kidney cancer	0.000369	0.00895	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Temsirolimus—kidney cancer	0.000364	0.00883	CcSEcCtD
SIMEPREVIR—Blood bilirubin increased—Paclitaxel—kidney cancer	0.000355	0.00861	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Pazopanib—kidney cancer	0.000343	0.00832	CcSEcCtD
SIMEPREVIR—SLCO1B1—renal system—kidney cancer	0.000343	0.0703	CbGeAlD
SIMEPREVIR—SLCO1B1—kidney—kidney cancer	0.000331	0.068	CbGeAlD
SIMEPREVIR—Anaemia—Temsirolimus—kidney cancer	0.000325	0.00788	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Everolimus—kidney cancer	0.000316	0.00768	CcSEcCtD
SIMEPREVIR—Anaemia—Pazopanib—kidney cancer	0.000306	0.00742	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Erlotinib—kidney cancer	0.000305	0.00741	CcSEcCtD
SIMEPREVIR—Hyperbilirubinaemia—Capecitabine—kidney cancer	0.000303	0.00735	CcSEcCtD
SIMEPREVIR—Myalgia—Temsirolimus—kidney cancer	0.000299	0.00726	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Temsirolimus—kidney cancer	0.000297	0.00721	CcSEcCtD
SIMEPREVIR—Blood bilirubin increased—Capecitabine—kidney cancer	0.000291	0.00706	CcSEcCtD
SIMEPREVIR—Infection—Temsirolimus—kidney cancer	0.000285	0.00691	CcSEcCtD
SIMEPREVIR—Myalgia—Pazopanib—kidney cancer	0.000282	0.00684	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Pazopanib—kidney cancer	0.00028	0.00679	CcSEcCtD
SIMEPREVIR—Skin disorder—Temsirolimus—kidney cancer	0.000279	0.00676	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Sorafenib—kidney cancer	0.000275	0.00666	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Everolimus—kidney cancer	0.000271	0.00657	CcSEcCtD
SIMEPREVIR—Infection—Pazopanib—kidney cancer	0.000269	0.00651	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Sunitinib—kidney cancer	0.000264	0.00641	CcSEcCtD
SIMEPREVIR—Skin disorder—Pazopanib—kidney cancer	0.000263	0.00637	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Temsirolimus—kidney cancer	0.000261	0.00634	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Erlotinib—kidney cancer	0.000261	0.00634	CcSEcCtD
SIMEPREVIR—Insomnia—Temsirolimus—kidney cancer	0.00026	0.00629	CcSEcCtD
SIMEPREVIR—Dyspnoea—Temsirolimus—kidney cancer	0.000256	0.0062	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Temsirolimus—kidney cancer	0.000248	0.00601	CcSEcCtD
SIMEPREVIR—Fatigue—Temsirolimus—kidney cancer	0.000247	0.006	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Pazopanib—kidney cancer	0.000246	0.00597	CcSEcCtD
SIMEPREVIR—Constipation—Temsirolimus—kidney cancer	0.000245	0.00595	CcSEcCtD
SIMEPREVIR—Insomnia—Pazopanib—kidney cancer	0.000244	0.00593	CcSEcCtD
SIMEPREVIR—Anaemia—Vinblastine—kidney cancer	0.000243	0.00588	CcSEcCtD
SIMEPREVIR—Photosensitivity reaction—Vincristine—kidney cancer	0.000242	0.00587	CcSEcCtD
SIMEPREVIR—Anaemia—Everolimus—kidney cancer	0.000242	0.00586	CcSEcCtD
SIMEPREVIR—Dyspnoea—Pazopanib—kidney cancer	0.000241	0.00584	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Sorafenib—kidney cancer	0.000235	0.0057	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Pazopanib—kidney cancer	0.000233	0.00566	CcSEcCtD
SIMEPREVIR—Fatigue—Pazopanib—kidney cancer	0.000233	0.00565	CcSEcCtD
SIMEPREVIR—Photosensitivity—Capecitabine—kidney cancer	0.000228	0.00552	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Sunitinib—kidney cancer	0.000226	0.00548	CcSEcCtD
SIMEPREVIR—Myalgia—Everolimus—kidney cancer	0.000223	0.0054	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Everolimus—kidney cancer	0.000221	0.00536	CcSEcCtD
SIMEPREVIR—Myalgia—Erlotinib—kidney cancer	0.000215	0.00521	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—kidney cancer	0.000213	0.00517	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Gemcitabine—kidney cancer	0.000212	0.00514	CcSEcCtD
SIMEPREVIR—Infection—Everolimus—kidney cancer	0.000212	0.00514	CcSEcCtD
SIMEPREVIR—Anaemia—Sorafenib—kidney cancer	0.00021	0.00509	CcSEcCtD
SIMEPREVIR—Skin disorder—Everolimus—kidney cancer	0.000207	0.00503	CcSEcCtD
SIMEPREVIR—Asthenia—Temsirolimus—kidney cancer	0.000206	0.00499	CcSEcCtD
SIMEPREVIR—Infection—Erlotinib—kidney cancer	0.000205	0.00496	CcSEcCtD
SIMEPREVIR—Pruritus—Temsirolimus—kidney cancer	0.000203	0.00492	CcSEcCtD
SIMEPREVIR—Anaemia—Sunitinib—kidney cancer	0.000202	0.0049	CcSEcCtD
SIMEPREVIR—Skin disorder—Erlotinib—kidney cancer	0.0002	0.00485	CcSEcCtD
SIMEPREVIR—Hyperbilirubinaemia—Doxorubicin—kidney cancer	0.000195	0.00474	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Everolimus—kidney cancer	0.000194	0.00472	CcSEcCtD
SIMEPREVIR—Asthenia—Pazopanib—kidney cancer	0.000194	0.0047	CcSEcCtD
SIMEPREVIR—Myalgia—Sorafenib—kidney cancer	0.000193	0.00469	CcSEcCtD
SIMEPREVIR—Insomnia—Everolimus—kidney cancer	0.000193	0.00468	CcSEcCtD
SIMEPREVIR—Photosensitivity reaction—Paclitaxel—kidney cancer	0.000192	0.00466	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—kidney cancer	0.000192	0.00465	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Vincristine—kidney cancer	0.000191	0.00464	CcSEcCtD
SIMEPREVIR—Pruritus—Pazopanib—kidney cancer	0.000191	0.00464	CcSEcCtD
SIMEPREVIR—Anaemia—Dactinomycin—kidney cancer	0.000191	0.00464	CcSEcCtD
SIMEPREVIR—Dyspnoea—Everolimus—kidney cancer	0.00019	0.00461	CcSEcCtD
SIMEPREVIR—Blood bilirubin increased—Doxorubicin—kidney cancer	0.000188	0.00455	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.000188	0.00455	CcSEcCtD
SIMEPREVIR—Insomnia—Erlotinib—kidney cancer	0.000186	0.00452	CcSEcCtD
SIMEPREVIR—Myalgia—Sunitinib—kidney cancer	0.000186	0.00451	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	0.000185	0.00448	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Everolimus—kidney cancer	0.000184	0.00447	CcSEcCtD
SIMEPREVIR—Infection—Sorafenib—kidney cancer	0.000184	0.00446	CcSEcCtD
SIMEPREVIR—Fatigue—Everolimus—kidney cancer	0.000184	0.00446	CcSEcCtD
SIMEPREVIR—Dyspnoea—Erlotinib—kidney cancer	0.000184	0.00445	CcSEcCtD
SIMEPREVIR—Constipation—Vinblastine—kidney cancer	0.000183	0.00444	CcSEcCtD
SIMEPREVIR—Constipation—Everolimus—kidney cancer	0.000183	0.00443	CcSEcCtD
SIMEPREVIR—CYP1A2—renal system—kidney cancer	0.000182	0.0374	CbGeAlD
SIMEPREVIR—Mediastinal disorder—Gemcitabine—kidney cancer	0.000181	0.0044	CcSEcCtD
SIMEPREVIR—Rash—Temsirolimus—kidney cancer	0.000181	0.00439	CcSEcCtD
SIMEPREVIR—Dermatitis—Temsirolimus—kidney cancer	0.000181	0.00438	CcSEcCtD
SIMEPREVIR—Skin disorder—Sorafenib—kidney cancer	0.00018	0.00436	CcSEcCtD
SIMEPREVIR—Headache—Temsirolimus—kidney cancer	0.00018	0.00436	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000178	0.00431	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Paclitaxel—kidney cancer	0.000178	0.00431	CcSEcCtD
SIMEPREVIR—Fatigue—Erlotinib—kidney cancer	0.000178	0.00431	CcSEcCtD
SIMEPREVIR—Infection—Sunitinib—kidney cancer	0.000177	0.0043	CcSEcCtD
SIMEPREVIR—Constipation—Erlotinib—kidney cancer	0.000176	0.00427	CcSEcCtD
SIMEPREVIR—Myalgia—Dactinomycin—kidney cancer	0.000176	0.00427	CcSEcCtD
SIMEPREVIR—Skin disorder—Sunitinib—kidney cancer	0.000173	0.0042	CcSEcCtD
SIMEPREVIR—Anaemia—Vincristine—kidney cancer	0.000171	0.00414	CcSEcCtD
SIMEPREVIR—Rash—Pazopanib—kidney cancer	0.00017	0.00413	CcSEcCtD
SIMEPREVIR—Nausea—Temsirolimus—kidney cancer	0.00017	0.00413	CcSEcCtD
SIMEPREVIR—Dermatitis—Pazopanib—kidney cancer	0.00017	0.00413	CcSEcCtD
SIMEPREVIR—Headache—Pazopanib—kidney cancer	0.000169	0.00411	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000169	0.00409	CcSEcCtD
SIMEPREVIR—Infection—Dactinomycin—kidney cancer	0.000168	0.00407	CcSEcCtD
SIMEPREVIR—Dyspnoea—Sorafenib—kidney cancer	0.000165	0.00401	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000162	0.00394	CcSEcCtD
SIMEPREVIR—Anaemia—Gemcitabine—kidney cancer	0.000162	0.00393	CcSEcCtD
SIMEPREVIR—Insomnia—Sunitinib—kidney cancer	0.000161	0.00391	CcSEcCtD
SIMEPREVIR—Nausea—Pazopanib—kidney cancer	0.000161	0.00389	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Sorafenib—kidney cancer	0.00016	0.00388	CcSEcCtD
SIMEPREVIR—Fatigue—Sorafenib—kidney cancer	0.00016	0.00387	CcSEcCtD
SIMEPREVIR—Dyspnoea—Sunitinib—kidney cancer	0.000159	0.00385	CcSEcCtD
SIMEPREVIR—Constipation—Sorafenib—kidney cancer	0.000158	0.00384	CcSEcCtD
SIMEPREVIR—Photosensitivity reaction—Capecitabine—kidney cancer	0.000158	0.00383	CcSEcCtD
SIMEPREVIR—Myalgia—Vincristine—kidney cancer	0.000157	0.00381	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000154	0.00373	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000154	0.00373	CcSEcCtD
SIMEPREVIR—Asthenia—Vinblastine—kidney cancer	0.000154	0.00373	CcSEcCtD
SIMEPREVIR—Fatigue—Sunitinib—kidney cancer	0.000154	0.00373	CcSEcCtD
SIMEPREVIR—Asthenia—Everolimus—kidney cancer	0.000153	0.00371	CcSEcCtD
SIMEPREVIR—Constipation—Sunitinib—kidney cancer	0.000152	0.0037	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Paclitaxel—kidney cancer	0.000152	0.00368	CcSEcCtD
SIMEPREVIR—Pruritus—Everolimus—kidney cancer	0.000151	0.00366	CcSEcCtD
SIMEPREVIR—Infection—Vincristine—kidney cancer	0.00015	0.00363	CcSEcCtD
SIMEPREVIR—Myalgia—Gemcitabine—kidney cancer	0.000149	0.00362	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000148	0.00359	CcSEcCtD
SIMEPREVIR—Asthenia—Erlotinib—kidney cancer	0.000148	0.00358	CcSEcCtD
SIMEPREVIR—Photosensitivity—Doxorubicin—kidney cancer	0.000147	0.00356	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Capecitabine—kidney cancer	0.000146	0.00353	CcSEcCtD
SIMEPREVIR—Pruritus—Erlotinib—kidney cancer	0.000146	0.00353	CcSEcCtD
SIMEPREVIR—Fatigue—Dactinomycin—kidney cancer	0.000146	0.00353	CcSEcCtD
SIMEPREVIR—Infection—Gemcitabine—kidney cancer	0.000142	0.00345	CcSEcCtD
SIMEPREVIR—Skin disorder—Gemcitabine—kidney cancer	0.000139	0.00337	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000137	0.00333	CcSEcCtD
SIMEPREVIR—Insomnia—Vincristine—kidney cancer	0.000136	0.00331	CcSEcCtD
SIMEPREVIR—Anaemia—Paclitaxel—kidney cancer	0.000136	0.00329	CcSEcCtD
SIMEPREVIR—Rash—Everolimus—kidney cancer	0.000135	0.00326	CcSEcCtD
SIMEPREVIR—Dermatitis—Everolimus—kidney cancer	0.000134	0.00326	CcSEcCtD
SIMEPREVIR—Headache—Vinblastine—kidney cancer	0.000134	0.00326	CcSEcCtD
SIMEPREVIR—Headache—Everolimus—kidney cancer	0.000134	0.00324	CcSEcCtD
SIMEPREVIR—Asthenia—Sorafenib—kidney cancer	0.000133	0.00322	CcSEcCtD
SIMEPREVIR—CYP3A4—renal system—kidney cancer	0.000132	0.0271	CbGeAlD
SIMEPREVIR—Pruritus—Sorafenib—kidney cancer	0.000131	0.00318	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.00013	0.00316	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Vincristine—kidney cancer	0.00013	0.00316	CcSEcCtD
SIMEPREVIR—Fatigue—Vincristine—kidney cancer	0.00013	0.00315	CcSEcCtD
SIMEPREVIR—Rash—Erlotinib—kidney cancer	0.00013	0.00315	CcSEcCtD
SIMEPREVIR—Dermatitis—Erlotinib—kidney cancer	0.00013	0.00315	CcSEcCtD
SIMEPREVIR—Insomnia—Gemcitabine—kidney cancer	0.000129	0.00314	CcSEcCtD
SIMEPREVIR—Headache—Erlotinib—kidney cancer	0.000129	0.00313	CcSEcCtD
SIMEPREVIR—Constipation—Vincristine—kidney cancer	0.000129	0.00313	CcSEcCtD
SIMEPREVIR—Asthenia—Sunitinib—kidney cancer	0.000128	0.0031	CcSEcCtD
SIMEPREVIR—CYP3A4—kidney—kidney cancer	0.000128	0.0262	CbGeAlD
SIMEPREVIR—Dyspnoea—Gemcitabine—kidney cancer	0.000128	0.00309	CcSEcCtD
SIMEPREVIR—Nausea—Vinblastine—kidney cancer	0.000127	0.00309	CcSEcCtD
SIMEPREVIR—Nausea—Everolimus—kidney cancer	0.000127	0.00307	CcSEcCtD
SIMEPREVIR—Pruritus—Sunitinib—kidney cancer	0.000126	0.00306	CcSEcCtD
SIMEPREVIR—Myalgia—Paclitaxel—kidney cancer	0.000125	0.00303	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Capecitabine—kidney cancer	0.000125	0.00302	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000124	0.00301	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000123	0.003	CcSEcCtD
SIMEPREVIR—Fatigue—Gemcitabine—kidney cancer	0.000123	0.00299	CcSEcCtD
SIMEPREVIR—Constipation—Gemcitabine—kidney cancer	0.000122	0.00297	CcSEcCtD
SIMEPREVIR—Nausea—Erlotinib—kidney cancer	0.000122	0.00297	CcSEcCtD
SIMEPREVIR—Asthenia—Dactinomycin—kidney cancer	0.000121	0.00294	CcSEcCtD
SIMEPREVIR—Infection—Paclitaxel—kidney cancer	0.000119	0.00289	CcSEcCtD
SIMEPREVIR—Rash—Sorafenib—kidney cancer	0.000117	0.00283	CcSEcCtD
SIMEPREVIR—Dermatitis—Sorafenib—kidney cancer	0.000117	0.00283	CcSEcCtD
SIMEPREVIR—Skin disorder—Paclitaxel—kidney cancer	0.000116	0.00282	CcSEcCtD
SIMEPREVIR—Headache—Sorafenib—kidney cancer	0.000116	0.00281	CcSEcCtD
SIMEPREVIR—Rash—Sunitinib—kidney cancer	0.000112	0.00273	CcSEcCtD
SIMEPREVIR—Dermatitis—Sunitinib—kidney cancer	0.000112	0.00272	CcSEcCtD
SIMEPREVIR—Headache—Sunitinib—kidney cancer	0.000112	0.00271	CcSEcCtD
SIMEPREVIR—Anaemia—Capecitabine—kidney cancer	0.000111	0.0027	CcSEcCtD
SIMEPREVIR—Nausea—Sorafenib—kidney cancer	0.00011	0.00267	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000109	0.00265	CcSEcCtD
SIMEPREVIR—Insomnia—Paclitaxel—kidney cancer	0.000108	0.00263	CcSEcCtD
SIMEPREVIR—Asthenia—Vincristine—kidney cancer	0.000108	0.00262	CcSEcCtD
SIMEPREVIR—Dyspnoea—Paclitaxel—kidney cancer	0.000107	0.00259	CcSEcCtD
SIMEPREVIR—Rash—Dactinomycin—kidney cancer	0.000106	0.00258	CcSEcCtD
SIMEPREVIR—Nausea—Sunitinib—kidney cancer	0.000106	0.00257	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000103	0.00251	CcSEcCtD
SIMEPREVIR—Fatigue—Paclitaxel—kidney cancer	0.000103	0.0025	CcSEcCtD
SIMEPREVIR—ABCB1—nephron tubule—kidney cancer	0.000103	0.0211	CbGeAlD
SIMEPREVIR—Asthenia—Gemcitabine—kidney cancer	0.000103	0.00249	CcSEcCtD
SIMEPREVIR—Myalgia—Capecitabine—kidney cancer	0.000103	0.00249	CcSEcCtD
SIMEPREVIR—Constipation—Paclitaxel—kidney cancer	0.000102	0.00248	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000102	0.00247	CcSEcCtD
SIMEPREVIR—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000102	0.00247	CcSEcCtD
SIMEPREVIR—Pruritus—Gemcitabine—kidney cancer	0.000101	0.00245	CcSEcCtD
SIMEPREVIR—Nausea—Dactinomycin—kidney cancer	0.0001	0.00243	CcSEcCtD
SIMEPREVIR—Infection—Capecitabine—kidney cancer	9.76e-05	0.00237	CcSEcCtD
SIMEPREVIR—Skin disorder—Capecitabine—kidney cancer	9.55e-05	0.00232	CcSEcCtD
SIMEPREVIR—Rash—Vincristine—kidney cancer	9.51e-05	0.00231	CcSEcCtD
SIMEPREVIR—Dermatitis—Vincristine—kidney cancer	9.5e-05	0.0023	CcSEcCtD
SIMEPREVIR—Headache—Vincristine—kidney cancer	9.45e-05	0.00229	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Doxorubicin—kidney cancer	9.39e-05	0.00228	CcSEcCtD
SIMEPREVIR—ABCB1—renal system—kidney cancer	9.35e-05	0.0192	CbGeAlD
SIMEPREVIR—ABCB1—kidney—kidney cancer	9.04e-05	0.0185	CbGeAlD
SIMEPREVIR—Rash—Gemcitabine—kidney cancer	9.02e-05	0.00219	CcSEcCtD
SIMEPREVIR—Dermatitis—Gemcitabine—kidney cancer	9.01e-05	0.00219	CcSEcCtD
SIMEPREVIR—Headache—Gemcitabine—kidney cancer	8.96e-05	0.00217	CcSEcCtD
SIMEPREVIR—Nausea—Vincristine—kidney cancer	8.96e-05	0.00217	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Capecitabine—kidney cancer	8.95e-05	0.00217	CcSEcCtD
SIMEPREVIR—Insomnia—Capecitabine—kidney cancer	8.89e-05	0.00216	CcSEcCtD
SIMEPREVIR—ABCB1—cortex of kidney—kidney cancer	8.8e-05	0.0181	CbGeAlD
SIMEPREVIR—Dyspnoea—Capecitabine—kidney cancer	8.76e-05	0.00213	CcSEcCtD
SIMEPREVIR—Asthenia—Paclitaxel—kidney cancer	8.59e-05	0.00208	CcSEcCtD
SIMEPREVIR—Nausea—Gemcitabine—kidney cancer	8.5e-05	0.00206	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Capecitabine—kidney cancer	8.48e-05	0.00206	CcSEcCtD
SIMEPREVIR—Fatigue—Capecitabine—kidney cancer	8.47e-05	0.00205	CcSEcCtD
SIMEPREVIR—Pruritus—Paclitaxel—kidney cancer	8.47e-05	0.00205	CcSEcCtD
SIMEPREVIR—Constipation—Capecitabine—kidney cancer	8.4e-05	0.00204	CcSEcCtD
SIMEPREVIR—ABCB1—gonad—kidney cancer	8.38e-05	0.0172	CbGeAlD
SIMEPREVIR—Mediastinal disorder—Doxorubicin—kidney cancer	8.04e-05	0.00195	CcSEcCtD
SIMEPREVIR—Rash—Paclitaxel—kidney cancer	7.55e-05	0.00183	CcSEcCtD
SIMEPREVIR—Dermatitis—Paclitaxel—kidney cancer	7.54e-05	0.00183	CcSEcCtD
SIMEPREVIR—Headache—Paclitaxel—kidney cancer	7.5e-05	0.00182	CcSEcCtD
SIMEPREVIR—Anaemia—Doxorubicin—kidney cancer	7.17e-05	0.00174	CcSEcCtD
SIMEPREVIR—Nausea—Paclitaxel—kidney cancer	7.11e-05	0.00173	CcSEcCtD
SIMEPREVIR—Asthenia—Capecitabine—kidney cancer	7.05e-05	0.00171	CcSEcCtD
SIMEPREVIR—Pruritus—Capecitabine—kidney cancer	6.95e-05	0.00169	CcSEcCtD
SIMEPREVIR—Myalgia—Doxorubicin—kidney cancer	6.61e-05	0.0016	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	6.56e-05	0.00159	CcSEcCtD
SIMEPREVIR—Infection—Doxorubicin—kidney cancer	6.29e-05	0.00153	CcSEcCtD
SIMEPREVIR—Rash—Capecitabine—kidney cancer	6.2e-05	0.0015	CcSEcCtD
SIMEPREVIR—Dermatitis—Capecitabine—kidney cancer	6.19e-05	0.0015	CcSEcCtD
SIMEPREVIR—Headache—Capecitabine—kidney cancer	6.16e-05	0.00149	CcSEcCtD
SIMEPREVIR—Skin disorder—Doxorubicin—kidney cancer	6.15e-05	0.00149	CcSEcCtD
SIMEPREVIR—Nausea—Capecitabine—kidney cancer	5.84e-05	0.00142	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Doxorubicin—kidney cancer	5.77e-05	0.0014	CcSEcCtD
SIMEPREVIR—Insomnia—Doxorubicin—kidney cancer	5.73e-05	0.00139	CcSEcCtD
SIMEPREVIR—Dyspnoea—Doxorubicin—kidney cancer	5.65e-05	0.00137	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Doxorubicin—kidney cancer	5.47e-05	0.00133	CcSEcCtD
SIMEPREVIR—Fatigue—Doxorubicin—kidney cancer	5.46e-05	0.00132	CcSEcCtD
SIMEPREVIR—Constipation—Doxorubicin—kidney cancer	5.42e-05	0.00131	CcSEcCtD
SIMEPREVIR—Asthenia—Doxorubicin—kidney cancer	4.55e-05	0.0011	CcSEcCtD
SIMEPREVIR—Pruritus—Doxorubicin—kidney cancer	4.48e-05	0.00109	CcSEcCtD
SIMEPREVIR—Rash—Doxorubicin—kidney cancer	3.99e-05	0.000969	CcSEcCtD
SIMEPREVIR—Dermatitis—Doxorubicin—kidney cancer	3.99e-05	0.000968	CcSEcCtD
SIMEPREVIR—Headache—Doxorubicin—kidney cancer	3.97e-05	0.000963	CcSEcCtD
SIMEPREVIR—Nausea—Doxorubicin—kidney cancer	3.76e-05	0.000913	CcSEcCtD
SIMEPREVIR—ABCB1—Allograft Rejection—VEGFA—kidney cancer	1.31e-05	0.000693	CbGpPWpGaD
SIMEPREVIR—ALB—Folate Metabolism—TP53—kidney cancer	1.3e-05	0.00069	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	1.29e-05	0.000687	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	1.28e-05	0.00068	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PDHB—kidney cancer	1.28e-05	0.000678	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—PIK3CA—kidney cancer	1.26e-05	0.000669	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Biological oxidations—GSTM1—kidney cancer	1.26e-05	0.000669	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metapathway biotransformation—GSTM1—kidney cancer	1.24e-05	0.00066	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—RAF1—kidney cancer	1.24e-05	0.000655	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—RELA—kidney cancer	1.23e-05	0.000652	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—ERBB2—kidney cancer	1.22e-05	0.000648	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—PIK3CA—kidney cancer	1.21e-05	0.000643	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—MTOR—kidney cancer	1.21e-05	0.00064	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—CD4—kidney cancer	1.2e-05	0.000638	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—CCBL1—kidney cancer	1.2e-05	0.000637	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Biological oxidations—CYP1A1—kidney cancer	1.2e-05	0.000634	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.19e-05	0.000629	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metapathway biotransformation—CYP1A1—kidney cancer	1.18e-05	0.000625	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—CA9—kidney cancer	1.18e-05	0.000623	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.15e-05	0.000609	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—CDKN1B—kidney cancer	1.13e-05	0.0006	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PDHB—kidney cancer	1.12e-05	0.000594	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—IL2—kidney cancer	1.11e-05	0.000587	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.09e-05	0.000576	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	1.08e-05	0.000572	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—JUN—kidney cancer	1.08e-05	0.000571	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—CTNNB1—kidney cancer	1.07e-05	0.000567	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Biological oxidations—GSTP1—kidney cancer	1.06e-05	0.000562	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CCBL1—kidney cancer	1.05e-05	0.000558	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—ACY1—kidney cancer	1.05e-05	0.000558	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	1.04e-05	0.000554	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—PTEN—kidney cancer	1.04e-05	0.000553	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—GLIPR1—kidney cancer	1.04e-05	0.000553	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PPAT—kidney cancer	1.04e-05	0.000553	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.03e-05	0.000546	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.02e-05	0.00054	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—CRABP1—kidney cancer	9.99e-06	0.00053	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Biological oxidations—GSTM1—kidney cancer	9.73e-06	0.000516	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—FH—kidney cancer	9.69e-06	0.000514	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—APRT—kidney cancer	9.69e-06	0.000514	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—IFNA1—kidney cancer	9.61e-06	0.00051	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	9.6e-06	0.000509	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	9.47e-06	0.000502	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—ITPR2—kidney cancer	9.29e-06	0.000493	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	9.23e-06	0.000489	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PPAT—kidney cancer	9.13e-06	0.000484	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—GLIPR1—kidney cancer	9.13e-06	0.000484	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—GPC3—kidney cancer	9.11e-06	0.000483	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	9.1e-06	0.000483	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	8.97e-06	0.000476	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—IFNA2—kidney cancer	8.94e-06	0.000474	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PDHB—kidney cancer	8.94e-06	0.000474	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Biological oxidations—POMC—kidney cancer	8.91e-06	0.000473	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—MAPK3—kidney cancer	8.9e-06	0.000472	CbGpPWpGaD
SIMEPREVIR—ALB—Transmembrane transport of small molecules—SLC5A5—kidney cancer	8.89e-06	0.000472	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—CA2—kidney cancer	8.86e-06	0.00047	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—ALAD—kidney cancer	8.63e-06	0.000458	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—RAF1—kidney cancer	8.6e-06	0.000456	CbGpPWpGaD
SIMEPREVIR—ALB—Transmembrane transport of small molecules—SLC2A1—kidney cancer	8.59e-06	0.000455	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	8.56e-06	0.000454	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—APRT—kidney cancer	8.49e-06	0.00045	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—FH—kidney cancer	8.49e-06	0.00045	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—MAPK1—kidney cancer	8.47e-06	0.000449	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—ACHE—kidney cancer	8.47e-06	0.000449	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—GSTT1—kidney cancer	8.47e-06	0.000449	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	8.47e-06	0.000449	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—ST3GAL2—kidney cancer	8.43e-06	0.000447	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CCBL1—kidney cancer	8.41e-06	0.000446	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	8.37e-06	0.000444	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—ALDH1A1—kidney cancer	8.24e-06	0.000437	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	8.19e-06	0.000434	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ACY1—kidney cancer	8.12e-06	0.00043	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—IGF2—kidney cancer	8.05e-06	0.000427	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—SCARB1—kidney cancer	8.02e-06	0.000425	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—KRAS—kidney cancer	8e-06	0.000424	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—GPC3—kidney cancer	7.98e-06	0.000423	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PTGS1—kidney cancer	7.94e-06	0.000421	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—SLC5A3—kidney cancer	7.9e-06	0.000419	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PGK1—kidney cancer	7.9e-06	0.000419	CbGpPWpGaD
SIMEPREVIR—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	7.79e-06	0.000413	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PSMD7—kidney cancer	7.78e-06	0.000413	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CA2—kidney cancer	7.76e-06	0.000412	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	7.76e-06	0.000411	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—LDHB—kidney cancer	7.74e-06	0.000411	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—IL2—kidney cancer	7.71e-06	0.000409	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	7.6e-06	0.000403	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—ALAD—kidney cancer	7.57e-06	0.000401	CbGpPWpGaD
SIMEPREVIR—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	7.52e-06	0.000399	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	7.4e-06	0.000392	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—ST3GAL2—kidney cancer	7.38e-06	0.000392	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	7.38e-06	0.000392	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—BCHE—kidney cancer	7.38e-06	0.000391	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—PIK3CA—kidney cancer	7.35e-06	0.00039	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	7.33e-06	0.000389	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—SLC5A5—kidney cancer	7.29e-06	0.000387	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GLIPR1—kidney cancer	7.29e-06	0.000387	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PPAT—kidney cancer	7.29e-06	0.000387	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—ALDH1A1—kidney cancer	7.22e-06	0.000383	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	7.2e-06	0.000382	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	7.14e-06	0.000379	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	7.12e-06	0.000378	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—SLC2A1—kidney cancer	7.04e-06	0.000373	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—SLC5A3—kidney cancer	6.92e-06	0.000367	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PGK1—kidney cancer	6.92e-06	0.000367	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PDHB—kidney cancer	6.9e-06	0.000366	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Biological oxidations—POMC—kidney cancer	6.88e-06	0.000365	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.83e-06	0.000362	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—LDHB—kidney cancer	6.79e-06	0.00036	CbGpPWpGaD
SIMEPREVIR—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	6.78e-06	0.00036	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—APRT—kidney cancer	6.78e-06	0.000359	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—FH—kidney cancer	6.78e-06	0.000359	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—CA9—kidney cancer	6.71e-06	0.000356	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Transmembrane transport of small molecules—RAF1—kidney cancer	6.71e-06	0.000356	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	6.62e-06	0.000351	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	6.56e-06	0.000348	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	6.55e-06	0.000347	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CCBL1—kidney cancer	6.49e-06	0.000344	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	6.45e-06	0.000342	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GPC3—kidney cancer	6.37e-06	0.000338	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CA2—kidney cancer	6.2e-06	0.000329	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	6.2e-06	0.000329	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	6.1e-06	0.000324	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—ALAD—kidney cancer	6.04e-06	0.00032	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.96e-06	0.000316	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	5.93e-06	0.000315	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	5.9e-06	0.000313	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—ST3GAL2—kidney cancer	5.89e-06	0.000313	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CA9—kidney cancer	5.88e-06	0.000312	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—GSTP1—kidney cancer	5.87e-06	0.000311	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	5.81e-06	0.000308	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—ALDH1A1—kidney cancer	5.76e-06	0.000306	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—CRABP1—kidney cancer	5.71e-06	0.000303	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PPAT—kidney cancer	5.62e-06	0.000298	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GLIPR1—kidney cancer	5.62e-06	0.000298	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—ABCB1—kidney cancer	5.56e-06	0.000295	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PGK1—kidney cancer	5.52e-06	0.000293	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—SLC5A3—kidney cancer	5.52e-06	0.000293	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	5.48e-06	0.000291	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—LDHB—kidney cancer	5.42e-06	0.000287	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—GSTM1—kidney cancer	5.4e-06	0.000286	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—ITPR2—kidney cancer	5.31e-06	0.000281	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—APRT—kidney cancer	5.23e-06	0.000277	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—FH—kidney cancer	5.23e-06	0.000277	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	5.12e-06	0.000271	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—CYP1A1—kidney cancer	5.12e-06	0.000271	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	5.04e-06	0.000267	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CRABP1—kidney cancer	5e-06	0.000265	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GPC3—kidney cancer	4.92e-06	0.000261	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.89e-06	0.000259	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	4.87e-06	0.000258	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—ACHE—kidney cancer	4.84e-06	0.000257	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—GSTT1—kidney cancer	4.84e-06	0.000257	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CA2—kidney cancer	4.78e-06	0.000254	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CA9—kidney cancer	4.7e-06	0.000249	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ALAD—kidney cancer	4.66e-06	0.000247	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—ITPR2—kidney cancer	4.65e-06	0.000247	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.59e-06	0.000243	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—SCARB1—kidney cancer	4.58e-06	0.000243	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ST3GAL2—kidney cancer	4.55e-06	0.000241	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PTGS1—kidney cancer	4.54e-06	0.000241	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PSMD7—kidney cancer	4.45e-06	0.000236	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ALDH1A1—kidney cancer	4.45e-06	0.000236	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—RAF1—kidney cancer	4.43e-06	0.000235	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PGK1—kidney cancer	4.26e-06	0.000226	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—SLC5A3—kidney cancer	4.26e-06	0.000226	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—GSTT1—kidney cancer	4.24e-06	0.000225	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—ACHE—kidney cancer	4.24e-06	0.000225	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—BCHE—kidney cancer	4.22e-06	0.000224	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.2e-06	0.000223	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—LDHB—kidney cancer	4.18e-06	0.000222	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—SLC5A5—kidney cancer	4.16e-06	0.000221	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—SLC2A1—kidney cancer	4.02e-06	0.000213	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—SCARB1—kidney cancer	4.01e-06	0.000213	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CRABP1—kidney cancer	3.99e-06	0.000212	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PTGS1—kidney cancer	3.97e-06	0.000211	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—IL2—kidney cancer	3.97e-06	0.000211	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.9e-06	0.000207	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PSMD7—kidney cancer	3.9e-06	0.000207	CbGpPWpGaD
SIMEPREVIR—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	3.84e-06	0.000203	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—POMC—kidney cancer	3.81e-06	0.000202	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—ITPR2—kidney cancer	3.71e-06	0.000197	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—BCHE—kidney cancer	3.69e-06	0.000196	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—SLC5A5—kidney cancer	3.65e-06	0.000194	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CA9—kidney cancer	3.62e-06	0.000192	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—SLC2A1—kidney cancer	3.52e-06	0.000187	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.42e-06	0.000182	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.4e-06	0.000181	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GSTT1—kidney cancer	3.39e-06	0.00018	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—ACHE—kidney cancer	3.39e-06	0.00018	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—VEGFA—kidney cancer	3.38e-06	0.000179	CbGpPWpGaD
SIMEPREVIR—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	3.36e-06	0.000178	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—GSTP1—kidney cancer	3.35e-06	0.000178	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—SCARB1—kidney cancer	3.2e-06	0.00017	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—MAPK3—kidney cancer	3.19e-06	0.000169	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—ABCB1—kidney cancer	3.18e-06	0.000168	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PTGS1—kidney cancer	3.17e-06	0.000168	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PSMD7—kidney cancer	3.11e-06	0.000165	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—GSTM1—kidney cancer	3.08e-06	0.000164	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CRABP1—kidney cancer	3.08e-06	0.000163	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PTGS2—kidney cancer	3.04e-06	0.000161	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—MAPK1—kidney cancer	3.04e-06	0.000161	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—BCHE—kidney cancer	2.95e-06	0.000156	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—GSTP1—kidney cancer	2.94e-06	0.000156	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—CYP1A1—kidney cancer	2.92e-06	0.000155	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—SLC5A5—kidney cancer	2.91e-06	0.000155	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—KRAS—kidney cancer	2.87e-06	0.000152	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ITPR2—kidney cancer	2.87e-06	0.000152	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—SLC2A1—kidney cancer	2.81e-06	0.000149	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.73e-06	0.000145	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—GSTM1—kidney cancer	2.7e-06	0.000143	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PTEN—kidney cancer	2.65e-06	0.000141	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—PIK3CA—kidney cancer	2.64e-06	0.00014	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GSTT1—kidney cancer	2.61e-06	0.000139	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ACHE—kidney cancer	2.61e-06	0.000139	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CYP1A1—kidney cancer	2.56e-06	0.000136	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—TP53—kidney cancer	2.55e-06	0.000135	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—SCARB1—kidney cancer	2.47e-06	0.000131	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PTGS1—kidney cancer	2.45e-06	0.00013	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.4e-06	0.000127	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PSMD7—kidney cancer	2.4e-06	0.000127	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.38e-06	0.000126	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GSTP1—kidney cancer	2.35e-06	0.000124	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—BCHE—kidney cancer	2.28e-06	0.000121	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—SLC5A5—kidney cancer	2.25e-06	0.000119	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—ABCB1—kidney cancer	2.22e-06	0.000118	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—POMC—kidney cancer	2.18e-06	0.000116	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—SLC2A1—kidney cancer	2.17e-06	0.000115	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GSTM1—kidney cancer	2.16e-06	0.000114	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CYP1A1—kidney cancer	2.04e-06	0.000108	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—POMC—kidney cancer	1.91e-06	0.000101	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PIK3CA—kidney cancer	1.87e-06	9.93e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GSTP1—kidney cancer	1.81e-06	9.6e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PTGS2—kidney cancer	1.74e-06	9.22e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ABCB1—kidney cancer	1.71e-06	9.09e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.68e-06	8.91e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GSTM1—kidney cancer	1.66e-06	8.83e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.58e-06	8.37e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—POMC—kidney cancer	1.52e-06	8.08e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PTGS2—kidney cancer	1.52e-06	8.08e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PTEN—kidney cancer	1.52e-06	8.04e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PTEN—kidney cancer	1.33e-06	7.04e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PTGS2—kidney cancer	1.22e-06	6.45e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—POMC—kidney cancer	1.18e-06	6.24e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PIK3CA—kidney cancer	1.07e-06	5.67e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PTEN—kidney cancer	1.06e-06	5.62e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PTGS2—kidney cancer	9.38e-07	4.98e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PIK3CA—kidney cancer	9.37e-07	4.97e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PTEN—kidney cancer	8.18e-07	4.34e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PIK3CA—kidney cancer	7.48e-07	3.97e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PIK3CA—kidney cancer	5.77e-07	3.06e-05	CbGpPWpGaD
